Palantir Technologies (NASDAQ:PLTR) has seen its share prices increase around 5% in the days following last week’s AIPCon 6, during which the ...
Given these promising results and a strong scientific rationale, combined with LX-101’s novel mechanism of action and prior positive clinical experience in oncology, Lirum is planning new clinical ...
If you’d like to remember the days before X, Engadget points out that an auction for one of two large signs from the company’s pre-acquisition San Francisco headquarters is close to ending. RR Auction ...